NCT03422796View on ClinicalTrials.gov

The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Migraine
Interventions
DRUG

Cilostazol 200mg

Cilostazol is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

SUMAtriptan 6 MG/ML

Cilostazol is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

DRUG

Placebo

Cilostazol is given both study days to induce headache. One day the headache is treated with placebo and the other day with sumatriptan

Trial Locations (1)

2600

Rigshospitalet Glostrup, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT03422796 - The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache | Biotech Hunter | Biotech Hunter